tiprankstipranks
Trending News
More News >
Sino Biopharmaceutical Ltd (HK:1177)
:1177
Hong Kong Market
Advertisement

Sino Biopharmaceutical (1177) Ownership - Who Owns Sino Biopharmaceutical?

Compare
20 Followers

Sino Biopharmaceutical (1177) Ownership Overview

10.92%2.93%<0.01%5.42%80.73%
10.92% Insiders
2.93%
Mutual Funds
<0.01% Other Institutional Investors
5.42% ETFs
80.73% Public Companies and
Individual Investors
The ownership structure of Sino Biopharmaceutical (HK:1177) stock is a mix of institutional, retail, and individual investors. Approximately 8.35% of the company’s stock is owned by Institutional Investors, 10.92% is owned by Insiders, and 80.73% is owned by Public Companies and Individual Investors.
The ownership structure of Sino Biopharmaceutical (HK:1177) stock is a mix of institutional, retail, and individual investors. Approximately 2.93% of the company’s stock is owned by Institutional Investors, 10.92% is owned by Insiders, and 5.42% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 22, 2025
xxxxxxxxxxxxx
HK$222179034
Aug 20, 2025
xxxxxxxxxxxxx
HK$7368000
Jul 16, 2025
xxxxxxxxxxxxx
HK$6470000
Oct 04, 2024
xxxxxxxxxxxxx
HK$51359460

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,688,774,241Insider9.00%1,766,457,856
398,446,938Institution2.12%416,775,497
359,557,270Insider1.92%376,096,904
319,642,862Institution1.70%334,346,434
150,917,412Institution0.80%157,859,613
139,775,818Institution0.75%146,205,506
121,597,990Institution0.65%127,191,498
101,643,942Institution0.54%106,319,563
55,496,750Institution0.30%58,049,601
46,363,352Institution0.25%48,496,066

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
150,917,412Institution0.80%157,859,613
139,775,818Institution0.75%146,205,506
121,597,990Institution0.65%127,191,498
46,363,352Institution0.25%48,496,066
19,744,936Institution0.11%20,653,203
18,269,662Institution0.10%19,110,066
15,554,000Institution0.08%16,269,484
5,678,071Institution0.03%5,939,262
5,171,000Institution0.03%5,408,866
4,523,500Institution0.02%4,731,581

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
141,281,818Institution0.75%135,305,783
127,719,444Institution0.68%122,317,079
97,257,000Institution0.52%96,377,923
28,755,000Institution0.15%28,495,092
24,116,500Institution0.13%23,826,691
24,116,500Institution0.13%23,826,691
21,521,750Institution0.11%21,327,221
21,072,718Institution0.11%20,181,366
19,525,000Institution0.10%18,643,968
19,525,000Institution0.10%18,643,968

FAQ

Who Owns Sino Biopharmaceutical Ltd (HK:1177)?
According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 10.92% is held by insiders, and 80.73% is held by retail investors.
    What percentage of Sino Biopharmaceutical Ltd (HK:1177) stock is held by institutional investors?
    According to the latest TipRanks data, approximately <0.01% of Sino Biopharmaceutical Ltd (HK:1177) stock is held by institutional investors.
      What percentage of Sino Biopharmaceutical Ltd (HK:1177) stock is held by retail investors?
      According to the latest TipRanks data, approximately 80.73% of Sino Biopharmaceutical Ltd (HK:1177) stock is held by retail investors.
        Who owns the most shares of Sino Biopharmaceutical Ltd (HK:1177)?
        Ping Tse owns the most shares of Sino Biopharmaceutical Ltd (HK:1177).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis